Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enoxaparin in ST elevation MI - a bright future

C P Cannon

    European Heart Journal
    |April 24, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

    American heart journal·2017
    Same author

    Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

    Diabetes, obesity & metabolism·2015
    Same author

    The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

    Alimentary pharmacology & therapeutics·2015
    Same author

    Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

    Lancet (London, England)·2015
    Same author

    Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy.

    Heart (British Cardiac Society)·2014
    Same author

    Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.

    Alimentary pharmacology & therapeutics·2010
    Same journal

    The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

    European heart journal·2026
    Same journal

    Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

    European heart journal·2026
    Same journal

    Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

    European heart journal·2026
    Same journal

    Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

    European heart journal·2026
    Same journal

    Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

    European heart journal·2026
    Same journal

    Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

    European heart journal·2026
    See all related articles